Vanguard Group’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-2,821,537
| Closed | -$288M | – | 4573 |
|
|
2023
Q2 | $288M | Buy |
2,821,537
+70,596
| +3% | +$7.2M | 0.01% | 1269 |
|
|
2023
Q1 | $250M | Buy |
2,750,941
+45,285
| +2% | +$4.12M | 0.01% | 1332 |
|
|
2022
Q4 | $103M | Buy |
2,705,656
+52,356
| +2% | +$1.99M | ﹤0.01% | 1792 |
|
|
2022
Q3 | $66.7M | Buy |
2,653,300
+33,890
| +1% | +$852K | ﹤0.01% | 2039 |
|
|
2022
Q2 | $79.6M | Sell |
2,619,410
-23,672
| -0.9% | -$719K | ﹤0.01% | 1952 |
|
|
2022
Q1 | $86.6M | Buy |
2,643,082
+85,409
| +3% | +$2.8M | ﹤0.01% | 2026 |
|
|
2021
Q4 | $67.4M | Buy |
2,557,673
+17,183
| +0.7% | +$453K | ﹤0.01% | 2185 |
|
|
2021
Q3 | $256M | Buy |
2,540,490
+1,930
| +0.1% | +$194K | 0.01% | 1445 |
|
|
2021
Q2 | $359M | Buy |
2,538,560
+104,061
| +4% | +$14.7M | 0.01% | 1222 |
|
|
2021
Q1 | $243M | Buy |
2,434,499
+114,468
| +5% | +$11.4M | 0.01% | 1472 |
|
|
2020
Q4 | $287M | Buy |
2,320,031
+205,934
| +10% | +$25.5M | 0.01% | 1230 |
|
|
2020
Q3 | $206M | Sell |
2,114,097
-89,454
| -4% | -$8.71M | 0.01% | 1261 |
|
|
2020
Q2 | $344M | Sell |
2,203,551
-36,177
| -2% | -$5.64M | 0.01% | 946 |
|
|
2020
Q1 | $323M | Buy |
2,239,728
+72,842
| +3% | +$10.5M | 0.01% | 866 |
|
|
2019
Q4 | $443M | Buy |
2,166,886
+335,461
| +18% | +$68.6M | 0.02% | 885 |
|
|
2019
Q3 | $147M | Buy |
1,831,425
+81,974
| +5% | +$6.58M | 0.01% | 1518 |
|
|
2019
Q2 | $165M | Buy |
1,749,451
+64,609
| +4% | +$6.1M | 0.01% | 1471 |
|
|
2019
Q1 | $144M | Buy |
1,684,842
+426,608
| +34% | +$36.5M | 0.01% | 1547 |
|
|
2018
Q4 | $70.6M | Buy |
1,258,234
+70,602
| +6% | +$3.96M | ﹤0.01% | 1853 |
|
|
2018
Q3 | $97.1M | Buy |
1,187,632
+509,326
| +75% | +$41.6M | ﹤0.01% | 1818 |
|
|
2018
Q2 | $23.7M | Buy |
678,306
+53,632
| +9% | +$1.88M | ﹤0.01% | 2496 |
|
|
2018
Q1 | $12.8M | Buy |
624,674
+12,032
| +2% | +$247K | ﹤0.01% | 2702 |
|
|
2017
Q4 | $17.3M | Buy |
612,642
+96,196
| +19% | +$2.72M | ﹤0.01% | 2540 |
|
|
2017
Q3 | $16.1M | Buy |
516,446
+220,906
| +75% | +$6.87M | ﹤0.01% | 2584 |
|
|
2017
Q2 | $9.35M | Buy |
295,540
+154,515
| +110% | +$4.89M | ﹤0.01% | 2812 |
|
|
2017
Q1 | $3.19M | Sell |
141,025
-1,855
| -1% | -$42K | ﹤0.01% | 3225 |
|
|
2016
Q4 | $3.12M | Buy |
142,880
+15,482
| +12% | +$338K | ﹤0.01% | 3211 |
|
|
2016
Q3 | $3.36M | Buy |
127,398
+79,483
| +166% | +$2.1M | ﹤0.01% | 3178 |
|
|
2016
Q2 | $946K | Buy |
+47,915
| New | +$946K | ﹤0.01% | 3616 |
|